InsiderFlow

Cameron Turtle

SYRE

Cameron Turtle serves as director, officer: Chief Executive Officer at Spyre Therapeutics, Inc. (SYRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

10 trades

$9.36M

Net Position

Net Seller

$9.36M

Companies Traded

1

SYRE

Active Period

Nov 2025 – Sep 2026

10 total trades

Most Recent

Sell SYRE

Sep 3, 2026 · $1.31M

Cameron Turtle's Insider Trading at Spyre Therapeutics, Inc. (SYRE)

Buys

0 · $0.00

Sells

10 · $9.36M

Total Shares Bought

0

Total Shares Sold

180,000

SYRE Price Chart
Loading chart...
DateTypeValue
Sep 3, 2026 Sell$1.31M
Aug 5, 2026 Sell$1.43M
Jul 2, 2026 Sell$1.32M
Jun 3, 2026 Sell$1.06M
May 1, 2026 Sell$1.07M
Apr 3, 2026 Sell$739.9K
Feb 2, 2026 Sell$492.0K
Jan 2, 2026 Sell$460.1K
Dec 1, 2025 Sell$435.4K
Nov 3, 2025 Sell$1.05M